Published in Lancet on October 06, 1984
Diagnostic deoxyribonucleic acid probes for infectious diseases. Clin Microbiol Rev (1988) 5.23
Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences. J Virol (1987) 3.16
Pathogenesis of malaria and clinically similar conditions. Clin Microbiol Rev (2004) 1.87
Human and viral gene detection in routine paraffin embedded tissue by in situ hybridisation with biotinylated probes: viral localisation in herpes encephalitis. J Clin Pathol (1986) 1.45
Rapid technique of DNA-DNA in situ hybridisation on formalin fixed tissue sections using microwave irradiation. J Clin Pathol (1987) 1.17
In vitro hepatitis B virus infection of human bone marrow cells. J Clin Invest (1986) 1.11
Age-dependent poliomyelitis of mice: expression of endogenous retrovirus correlates with cytocidal replication of lactate dehydrogenase-elevating virus in motor neurons. J Virol (1989) 0.99
In situ hybridisation in formalin fixed, paraffin wax embedded liver specimens: method for detecting human and viral DNA using biotinylated probes. J Clin Pathol (1988) 0.86
Participating in the evolution of transfusion medicine from a dispensary into a discipline. Transfus Med Rev (2008) 0.78
Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers. Br J Cancer (1990) 0.77
Expression of ecotropic murine leukemia virus in the brains of C58/M, DBA2/J, and in utero-infected CE/J mice. J Virol (1995) 0.76
Immunodiagnosis of viral hepatitides A to E and non-A to -E. Clin Diagn Lab Immunol (1996) 0.75
Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (1993) 11.15
Changes in thymic function with age and during the treatment of HIV infection. Nature (1998) 10.27
Detection of viral sequences of low reiteration frequency by in situ hybridization. Proc Natl Acad Sci U S A (1978) 7.95
Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science (1999) 7.66
Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol (1997) 6.61
Hemagglutination assay for antigen and antibody associated with viral hepatitis. Science (1970) 5.81
Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science (1997) 5.55
Biology of hepatitis B virus. Science (1981) 4.93
Pathogenesis of lentivirus infections. Nature (1986) 4.61
The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein. Virology (2001) 3.25
The slow infection caused by visna virus. Curr Top Microbiol Immunol (1975) 2.99
Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. J Virol (2000) 2.89
Slow persistent infection caused by visna virus: role of host restriction. Science (1977) 2.83
Simultaneous in situ detection of viral RNA and antigens. Proc Natl Acad Sci U S A (1984) 2.73
New aspects of an anti-tumour drug: sorafenib efficiently inhibits HCV replication. Gut (2009) 2.72
Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. J Infect Dis (2001) 2.63
A new rapid method for genetic typing of human immunoglobulins. J Immunol (1968) 2.61
Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization. JAMA (1985) 2.48
Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J Virol (1991) 2.47
Visna DNA synthesis and the tempo of infection in vitro. Virology (1982) 2.47
Determinants for membrane association of the hepatitis C virus RNA-dependent RNA polymerase. J Biol Chem (2001) 2.45
Anaphylactoid transfusion reactions associated with anti-IgA. Lancet (1968) 2.40
Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection. Proc Natl Acad Sci U S A (1998) 2.39
State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases. Proc Natl Acad Sci U S A (1981) 2.37
Partial amino acid sequence of two major component polypeptides of hepatitis B surface antigen. Proc Natl Acad Sci U S A (1977) 2.34
Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway. J Virol (1999) 2.24
The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med (1995) 2.21
Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology (2000) 2.15
Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc Natl Acad Sci U S A (1997) 2.11
Detection of two viral genomes in single cells by double-label hybridization in situ and color microradioautography. Science (1985) 2.09
Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA (1987) 2.08
Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins. Hepatology (1998) 2.05
Gene expression in visna virus infection in sheep. Nature (1981) 1.98
Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells. N Engl J Med (1991) 1.95
Cutting edge: In situ tetramer staining of antigen-specific T cells in tissues. J Immunol (2000) 1.92
Primary hepatocellular carcinoma. N Engl J Med (1991) 1.91
Enzymatic amplification of hepatitis B virus DNA in serum compared with infectivity testing in chimpanzees. J Infect Dis (1989) 1.88
Hepatitis-associated Australia antigen. Protein, peptides and amine acid composition of purified antigen with its use in determining sensitivity of the hemagglutination test. J Immunol (1972) 1.83
Antigenic variation in visna virus. Cell (1979) 1.81
Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant. Proc Natl Acad Sci U S A (1982) 1.81
The structural polypeptides of RNA slow viruses. Virology (1974) 1.81
Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology (1996) 1.80
Analysis of human immunodeficiency virus-infected tissues by amplification and in situ hybridization reveals latent and permissive infections at single-cell resolution. Proc Natl Acad Sci U S A (1993) 1.79
Generation of stable mRNA fragments and translation of N-truncated proteins induced by antisense oligodeoxynucleotides. Mol Cell (2001) 1.74
Australia antigen (hepatitis B antigen): a conformational antigen dependent on disulfide bonds. Science (1972) 1.72
An error model for protein quantification. Bioinformatics (2007) 1.72
Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase. J Clin Invest (1990) 1.70
Hepatitis B "immune" globulin: effectiveness in prevention of dialysis-associated hepatitis. N Engl J Med (1975) 1.66
Immune response to hepatitis B surface antigen. Infect Immun (1975) 1.59
Successful treatment of gastrointestinal vasculitis due to systemic lupus erythematosus with intravenous pulse cyclophosphamide: a clinical case report and review of the literature. Br J Rheumatol (1998) 1.56
Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapy. J Infect Dis (2000) 1.51
Visna virus DNA: discovery of a novel gapped structure. Virology (1981) 1.51
Asymmetric replication of hepatitis B virus DNA in human liver: demonstration of cytoplasmic minus-strand DNA by blot analyses and in situ hybridization. Virology (1984) 1.48
Visna virus RNA synthesis. J Virol (1977) 1.48
Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet (1997) 1.47
Measles virus nucleotide sequences: detection by hybridization in situ. Science (1981) 1.45
Scrapie-associated prion protein accumulates in astrocytes during scrapie infection. Proc Natl Acad Sci U S A (1991) 1.45
Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. J Virol (1994) 1.44
Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular carcinoma. Lancet (1999) 1.43
Genetic evaluation of suspected cases of transient HIV-1 infection of infants. Science (1998) 1.43
Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis. J Virol (2000) 1.41
[Local ablation of malignant lesions of the liver - potential applications and limitations of the different methods]. Z Gastroenterol (2004) 1.41
Interactions of human cytomegalovirus with leukocytes in vivo: analysis by in situ hybridization. Microb Pathog (1987) 1.39
[A rare cause of an indistinct liver lesion in an elderly woman]. Dtsch Med Wochenschr (2011) 1.39
Reduction of human immunodeficiency virus-infected cells from donor blood by leukocyte filtration. Transfusion (1989) 1.38
[Liver diseases in pregnancy]. Dtsch Med Wochenschr (2008) 1.38
Detection of hepatitis B virus DNA in hepatocytes, bile duct epithelium, and vascular elements by in situ hybridization. Proc Natl Acad Sci U S A (1983) 1.37
Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus. J Virol (2001) 1.33
Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am J Gastroenterol (2001) 1.32
Assessment of human immunodeficiency virus expression in cocultures of peripheral blood mononuclear cells from healthy seropositive subjects. J Med Virol (1988) 1.32
Complete nucleotide sequence of a German duck hepatitis B virus. Nucleic Acids Res (1990) 1.31
Serologic specificity of hun anti-IgA and its significance in transfusion. Blood (1969) 1.30
Molecular characterization of a new variant of hepatitis B virus in a persistently infected homosexual man. Hepatology (1990) 1.28
Polymerase chain reaction compared with concurrent viral cultures for rapid identification of human immunodeficiency virus infection among high-risk infants and children. J Pediatr (1989) 1.28
Synthesis in cell culture of the gapped linear duplex DNA of the slow virus visna. Virology (1985) 1.27
A precore-defective mutant of hepatitis B virus associated with e antigen-negative chronic liver disease. J Med Virol (1990) 1.27
Isolation of replication-competent molecular clones of visna virus. Virology (1991) 1.26
Hepatitis B virus infection in patients with idiopathic liver disease. Hepatology (1991) 1.23
Protective attenuated lentivirus immunization induces SIV-specific T cells in the genital tract of rhesus monkeys. Mucosal Immunol (2008) 1.22
A sphincterotome-based technique for selective transpapillary common bile duct cannulation. Gastrointest Endosc (2000) 1.21
Complete nucleotide sequence of a Chinese duck hepatitis B virus. Nucleic Acids Res (1990) 1.20
Serological definition of the lentivirus group of retroviruses. J Virol (1979) 1.20
Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection. J Clin Invest (1999) 1.19
A comparison of the high molecular weight RNAs of visna virus and Rous sarcoma virus. Virology (1974) 1.18
Demonstration of a DNA provirus in the lytic growth of visna virus. Nat New Biol (1973) 1.18
Serum markers of hepatocellular carcinoma. Semin Liver Dis (2006) 1.17
Detection of visna virus antigens and RNA in glial cells in foci of demyelination. Virology (1985) 1.17
Mengovirus-induced cytopathic effect in L-cells: protective effect of interferon. J Virol (1969) 1.16
Reversibility of the pathological changes in the follicular dendritic cell network with treatment of HIV-1 infection. Proc Natl Acad Sci U S A (1999) 1.16
A comparative study of hepatitis B viral markers in the family members of Asian and non-Asian patients with hepatitis B surface antigen-positive hepatocellular carcinoma and with chronic hepatitis B infection. J Infect Dis (1979) 1.15
Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol (2001) 1.15
Spot-blot hybridization assay for the detection of hepatitis B virus DNA in serum: factors determining its sensitivity and specificity. Hepatology (1987) 1.15